Publikationen, an denen er mitarbeitet Dolores Rodríguez (18)

2024

  1. Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 7, pp. 354-360

  2. Impact of antibiotic prophylaxis in second-stage surgery in joint prosthesis infection treated with two-stage exchange. A multicenter case–control study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 7, pp. 1319-1328

2023

  1. Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study

    Antibiotics, Vol. 12, Núm. 3

  2. Vertebral osteomyelitis after spine instrumentation surgery: risk factors and management

    Journal of Hospital Infection, Vol. 140, pp. 102-109

2022

  1. Corrigendum to “Prognosis of unexpected positive intraoperative cultures in arthroplasty revision: A large multicenter cohort” [Journal of Infection 83 (2021) 542–549] (Journal of Infection (2021) 83(5) (542–549), (S0163445321004527), (10.1016/j.jinf.2021.09.001))

    Journal of Infection

2021

  1. Implant removal in the management of prosthetic joint infection by staphylococcus aureus: Outcome and predictors of failure in a large retrospective multicenter study

    Antibiotics, Vol. 10, Núm. 2, pp. 1-13

  2. Prognosis of unexpected positive intraoperative cultures in arthroplasty revision: A large multicenter cohort

    Journal of Infection, Vol. 83, Núm. 5, pp. 542-549

  3. Prosthetic shoulder joint infection by Cutibacterium acnes: Does rifampin improve prognosis? A retrospective, multicenter, observational study

    Antibiotics, Vol. 10, Núm. 5

  4. Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 11, pp. 2411-2419

2020

  1. Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 26, Núm. 4, pp. 499-505

2019

  1. The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms

    Journal of Clinical Medicine, Vol. 8, Núm. 5

2017

  1. The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: The results of a large multicenter study

    Clinical Infectious Diseases, Vol. 64, Núm. 12, pp. 1742-1752

2016

  1. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial

    International Journal of Antimicrobial Agents, Vol. 48, Núm. 3, pp. 310-316

  2. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8

2014

  1. Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: A multi-national study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. 1219-1224

  2. Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. O911-O919

2013

  1. A large multicenter study of methicillin-susceptible and methicillin-resistant staphylococcus aureus prosthetic joint infections managed with implant retention

    Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 182-194

  2. Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria

    Diagnostic Microbiology and Infectious Disease, Vol. 76, Núm. 1, pp. 93-98